Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | SCN4A | P35499 | 7/20 | 0.50 |
| ▸ | DPP4 | P27487 | 2/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43945 | 1.00 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL29503095 | 1.00 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL176808 | 1.00 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| Benzene SCHEMBL28170835 | 1.00 | SLC6A4 (0.56) | SLC6A4LMNASCN4ADPP4F2 | |
| SCHEMBL28382272 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Iodide SCHEMBL6672339 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL7185884 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL5945406 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL6852974 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 | |
| Hydrochloric Acid SCHEMBL1607928 | 0.97 | SLC6A4 (0.54) | SLC6A4LMNASCN4ADPP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 937 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250078176-A1 | ENVIRONMENTAL ATTRIBUTES FOR NITROGEN CONTAINING CHEMICALS | BASF SE (DE) | 2025-03-06 | — | — | US | claimed |
| CN-119119035-A | RIPK1 kinase target inhibitor and preparation method and application thereof | 中山大学 | 2024-12-13 | — | — | CN | claimed |
| CN-118946165-A | Interface interaction spin-photon conversion body heterostructure and preparation method | 武汉大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118745344-A | Perovskite circular polarization luminescent material with chiral low-dimensional-three-dimensional heterojunction structure and application thereof | 武汉大学 | 2024-10-08 | — | — | CN | claimed |
| CN-118435582-A | Environmental attributes of nitrogen-containing chemicals | 巴斯夫欧洲公司 | 2024-08-02 | — | — | CN | claimed |
| CN-115515957-B | Stereoselective synthesis of intermediates for the preparation of heterocyclic compounds | 太景生物科技股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-115667222-B | Method for preparing GLP-1 receptor agonist | 杭州中美华东制药有限公司 | 2023-09-29 | — | — | CN | claimed |
| WO-2023117926-A1 | ENVIRONMENTAL ATTRIBUTES FOR NITROGEN CONTAINING CHEMICALS | BASF SE (DE) | 2023-06-29 | — | — | WO | claimed |
| EP-4157841-A1 | STEREOSELECTIVE SYNTHESIS OF INTERMEDIATE FOR PREPARATION OF HETEROCYCLIC COMPOUND | Taigen Biotechnology Co., Ltd. (TW) | 2023-04-05 | — | — | EP | claimed |
| US-20230048657-A1 | PROCESS FOR THE PREPARATION OF (9S)-2-BROMO-9-(2,3,4-TRIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-[1,2,4]TRIAZOLO[1,5-A]AZEPINE | HOFFMANN-LA ROCHE INC. (US) | 2023-02-16 | — | — | US | claimed |
| US-6780875-B2 | RESPIRATORY SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS; PSYCHOLOGICAL DISORDERS | SMITHKLINE BEECHAM S.P.A. (IT) | 2004-08-24 | — | — | US | claimed |
| US-20040049031-A1 | Method for the synthesis of quinoline derivatives | SMITHKLINE BEECHAM CORPORATION | 2004-03-11 | — | — | US | claimed |
| US-6677337-B2 | RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, INFLAMMATORY BOWEL DISEASE, CACHEXIA, SEPTIC SHOCK, CARDIOVASCULAR AND RESPIRATORY SYSTEM DISORDERS | THE PROCTER & GAMBLE COMPANY | 2004-01-13 | — | — | US | claimed |
| US-20030225082-A1 | 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines | PROCTER & GAMBLE COMPANY, THE | 2003-12-04 | — | — | US | claimed |
| CN-1125815-C | Method for the synthesis of quinoline derivatives | SMITHKLINE BEECHAM CORP (US) | 2003-10-29 | — | — | CN | claimed |
| WO-2003080184-A1 | 1,2-DIHYDROPYRAZOL-3-ONES AS CYTOKINE MEDIATORS | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-02 | — | — | WO | claimed |
| US-20020173657-A1 | Method for the synthesis of quinoline derivatives | SMITHKLINE BEECHAM CORPORATION | 2002-11-21 | — | — | US | claimed |
| US-20020038029-A1 | Reacting 3-hydroxy-2-phenylquinoline-4-carboxylic acid, in solvent with riethyl amine, cooling,adding thionyl chloride; adding phenyl propylamine, heating to form (-)-(S)-N( alpha -ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide | SMITHKLINE BEECHAM CORPORATION | 2002-03-28 | — | — | US | claimed |
| US-6335448-B1 | NK-3 RECEPTOR ANTAGONISTS ARE USEFUL IN TREATING THE SYMPTOMS OF COPD AND URINARY INCONTINENCE IN MAMMALS. | SMITHKLINE BEECHAM CORPORATION | 2002-01-01 | — | — | US | claimed |
| CN-1278796-A | Method for the synthesis of quinoline derivatives | SMITHKLINE BEECHAM CORP (US) | 2001-01-03 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230048657-A1 | PROCESS FOR THE PREPARATION OF (9S)-2-BROMO-9-(2,3,4-TRIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-[1,2,4]TRIAZOLO[1,5-A]AZEPINE | APP, PSEN1, PSEN2 | SLC6A4 466/4885LMNA 1617/4885SCN4A 2899/4885 |
| US-20020038029-A1 | Reacting 3-hydroxy-2-phenylquinoline-4-carboxylic acid, in solvent with riethyl amine, cooling,adding thionyl chloride; adding phenyl propylamine, heating to form (-)-(S)-N( alpha -ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide | RPP30, HPD, HRH4 | SLC6A4 479/4885LMNA 4118/4885SCN4A 120/4885 |
| US-20020173657-A1 | Method for the synthesis of quinoline derivatives | NQO2, QARS1, QPCT | SLC6A4 2032/4885LMNA 1996/4885SCN4A 1419/4885 |
| US-20030225082-A1 | 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines | IL1B, IL1A, IL1R1 | SLC6A4 4829/4885LMNA 2484/4885SCN4A 3331/4885 |
| US-20040049031-A1 | Method for the synthesis of quinoline derivatives | NQO2, NQO1, CYP3A4 | SLC6A4 316/4885LMNA 1836/4885SCN4A 679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.